{{ storiesRelated.title }}

International Companies
cb biogen
Biogen dives after canning Alzheimer's drug trials

Biogen shares plummeted on Thursday after the company confirmed that it will cease clinical trials for aducanumab, the experimental Alzheimer’s disease treatment it developed alongside its Nikkei 225-listed Japanese partner Eisai.

20 Mar
ubs2 portada
Investment banking enduring worst quarter 'in recent history' - UBS

The chief executive of UBS has called the last three months one of the worst quarters in investment banking’s recent history.

20 Mar
ep boeing 777 freighterfedex
FedEx drops as quarterly growth overseas and at key division underwhelm

International courier services and air freight giant FedEx reported a sharp drop in both sales and profits for its third quarter, blaming its weaker-than-expected performance on its international arm.

20 Mar
ep edificiopfizer
Pfizer buys 15% stake in French gene therapy company Vivet

US pharmaceutical group Pfizer has bought a 15% stake in Vivet Therapeutics and now has an exclusive option to buy out the rest of the privately-held French gene therapy company.

20 Mar
cb google workers
Google hit with €1.49bn fine for EU antitrust breaches

Google has been slapped with a €1. 49bn fine by the European Commission for breaking EU antitrust rules by abusing its market dominance in online advertising.

20 Mar
Bayer shares pummeled after ruling against firm's herbicide

Shares of Bayer were unwanted on Wednesday after a California jury issued a preliminary ruling against the German chemicals maker.

20 Mar
ep logo toyota 20181219122502
Toyota and Suzuki look to boost hybrid presence via global tie-up

Japan’s Toyota Motor Corporate and Suzuki Motor Corporation have unveiled plans for a wide-ranging collaboration, including jointly producing electric vehicles.

20 Mar
BMW shares slide on profit warning

Shares in BMW slid on Wednesday as the German car maker warned that 2019 pre-tax profit would be "well below" the previous year's level amid rising manufacturing costs and announced a new cost-savings plan.

20 Mar
glencore 20171129180418
Aeris Resources offers $575m for Glencore's CSA copper mine

Australian copper producer Aeris Resources has offered to buy Glencore's CSA copper mine in New South Wales for $575m.

19 Mar
FCA fines UBS £27.6m for dire reporting of deals

The City watchdog has fined UBS more than £27m for failing to keep proper records on nearly 136m transactions over a decade.

19 Mar
Investors sue Danske Bank for $475m over money laundering

Institutional investors are suing Danske Bank for $475m of damages in connection with the money laundering scandal that hit the Danish bank last year.

19 Mar
meeting, takeover, talks, bid, merger, acquisition, board
Jones Lang LaSalle to buy HFF in $2bn deal

Jones Lang LaSalle has agreed to buy capital markets services provider HFF in a cash and stock deal worth about $2bn.

19 Mar
cb deutsche bankk commerzb
ECB scepticism could threaten Deutsche-Commerzbank deal

Deutsche Bank’s mooted merger with Commerzbank could face opposition from the European Central Bank after the eurozone’s leading financial supervisor said he disliked the idea of national banking champions.

19 Mar
ep roche 20190211134104
Roche gets FDA approval for Tecentriq chemotherapy combination

Roche announced on Tuesday that the US Food and Drug Administration (FDA) has approved ‘Tecentriq’ (atezolizumab), in combination with carboplatin and etoposide chemotherapy, for the initial treatment of adults with extensive-stage small cell lung cancer.

19 Mar
ep productorcannabis tilray compra manitoba harvest280 millones
Tilray revenues and losses widen in fourth quarter

Canadian marijuana outfit Tilray posted a wider than expected fourth-quarter loss even though revenues were bigger than forecast.

19 Mar
Lyft plots route to $2.1bn IPO

Ride hailing firm Lyft expects to raise up to $2. 1bn in its upcoming initial public offering, it announced on Monday.

18 Mar
Drugs, pharmaceuticals, medical
Dermira shares rocket after positive drug trial

Shares in Nasdaq’s Dermira have more than doubled after the biopharmaceutical company unveiled positive trials for a possible new eczema treatment.

18 Mar
ep deutsche bank 20190204145403
Commerzbank and Deutsche Bank confirm merger talks; shares jump

Shares in Deutsche Bank and its smaller rival Commerzbank rallied on Monday, after the two banks confirmed long-held speculation they were in merger talks.

18 Mar
FIS to buy Worldpay in $43bn cash and stock deal

Payments processor Worldpay has agreed to be bought by US financial services technology company FIS in a $43bn deal.